Membrane Type-1 Matrix Metalloproteinase Promotes Human Melanoma Invasion and Growth

Journal of Investigative Dermatology

Volumn 122, Issue 1, 2004, Pages 167-176

  Iida, Joji ^a,b   Wilhelmson, Krista L ^a   Price, Matthew A ^a   Wilson, Christopher M ^a   Pei, Duanqing ^b,c   Furcht, Leo T ^a,b   McCarthy, James B ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Growth; Invasion; Melanoma

Indexed keywords

AGAROSE; BATIMASTAT; COLLAGEN TYPE 1; COLLAGEN TYPE 4; LAMININ 1; MATRIGEL; MATRIX METALLOPROTEINASE 14;

ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENICITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE;

EID: 1642559381     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2003.22114.x     Document Type: Article

References (62)

1. Ahonen M, Baker A, Kahari V: Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 58:210-2315, 1998
2. Albini A: Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol Oncol Res 4:230-241, 1998
3. Atkinson S, Crabbe T, Cowell S, et al: Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membrane. J Biol Chem 270:30479-30485, 1995
4. Aznavoorian S, Moore BA, Alexander-Lister LD, Hallit SL, Windsor LJ, Engler JA: Membrane type 1-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Cancer Res 61:6264-6275, 2001
5. Benbow U, Schoenermark MP, Mitchell TI, Rutter JL, Shimokawa K, Nagase H, Brinckerhoff CE: A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem 274:25371-25378, 1999
6. Cifone M: In vitro growth characteristics associated with benign and metastatic variants of tumor cells. Cancer Metastasis Rev 1:335-347, 1982
7. Cornil I, Man S, Fernandez B, Kerbel R: Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice. J Natl Cancer Inst 81:938-944, 1989
8. Deryugina E, Soroceanu L, Strongin A: Up-regulation of vascular endothelial growth factor by membrane-type I matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res 62:580-588, 2002
9. Ding R, Yokoyama Y, Ramakrishnan S, Griffioen A, Mayo K: The designed angiogenic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin. Cancer Res 63:382-385, 2003
10. Durko M, Navab R, Shibata HR, Brodt P: Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1. Biochim Biophys Acta 1356:271-280, 1997
11. Ellerbroek SM, Wu YI, Overall CM, Stack MS: Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 276:24833-24842, 2001
12. Faassen A, Schrager J, Klein D, Oegema T, Couchman J, McCarthy J: A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 116:521-531, 1992
13. Freedman V, Shin S: Cellular tumorigenicity in nude mice: Correlation with cell growth in semi-solid medium. Cell 3:355-359, 1974
14. Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre M, Anaabi B, Beliveau R: Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett 507:231-236, 2001
15. Hofmann U, Westphal J, Waas E, Zendman A, Cornelissen I, Ruiter D, van Muijen G: Matrix metalloproteinases in human melanoma cell lines and xenografts: Increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 81:774-782, 1999
16. Hofmann U, Westphal J, van Muijen G, Ruiter D: Matrix metalloproteinases in human melanoma. J Invest Dermatol 115:337-344, 2000
17. Hornebeck W, Emonnard H, Monboisse J, BG: Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 12:231-241, 2002
18. Hotary K, Allen E, Punturrieri A, Yana I, Weiss S: Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinase. J Cell Biol 149:1309-1323, 2000
19. Hotary K, Yana I, Sabeh F, et al: Matrix metalloproteinases (MMP) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J Exp Med 195:295-308, 2002
20. Houghton AN, Polsky D: Focus on melanoma. Cancer Cell 2:275-278, 2002
21. Iida J, Pei D, Kang T, Simpson M, Herlyn M, Furcht L, McCarthy J: Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase- dependent human melanoma invasion into type I collagen. J Biol Chem 276:18786-18794, 2001
22. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S: Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58:1048-1051, 1998
23. Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R, Uehira M: Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17:177-181, 1999
24. Karsdal M, Larsen L, Engsig M, et al: MMP dependent activation of latent TGF-β controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem DOI:10.1074/jbe.M207205200, 2002
25. Khokka R: Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86:299-304, 1994
26. Knutson J, Iida J, Fields G, McCarthy J: CD44/chondroitin sulfate proteoglycan and a2b1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol Biol Cell 7:383-396, 1996
27. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V: Role of cell surface metalloproteinase MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148:615-624, 2000
28. Kurschat P, Zigrino P, Nischt R, et al: Tissue inhibitor of matrix metalloporoteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem 274:21056-21062, 1999
29. Lehti K, Valtanen H, Wickstrom S, Lohi J, Keski-Oja J: Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 275:15006-15013, 2000
30. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L: EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1:445-457, 2002
31. MacDougall J, Matrisian L: Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14:351-362, 1995
32. MacDougall JR, Bani MR, Lin Y, Muschel RJ, Kerbel RS: "Proteolytic switching": Opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression. Br J Cancer 80:504-512, 1999
33. Mackay AR, Gomez DE, Nason AM, Thorgeirsson UP: Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression [see comments]. Lab Invest 70:800-806, 1994
34. Maquoi E, Noel A, Frankenne F, Angliker H, Murphy G, Foidart J: Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett 424:262-266, 1998
35. McCawley L, Matrisian L: Matrix metalloproteinases: They're not just matrix anymore!. Curr Opin Cell Biol 13:534-540, 2001
36. Monea S, Lehti K, Keski-Oja J, Mignatti P: Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type I matrix metalloproteinase-dependent mechanisms. J Cell Physiol 192:160-170, 2002
37. Nagase H, Woessner Jr J: Matrix metalloproteinases. J Biol Chem 274:21491-21494, 1999
38. Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh YY, Chen WT: Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloproteinase docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA 94:7959-7964, 1997
39. Patarroyo M, Tryggavson K, Virtanen I: Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 12:197-207, 2002
40. Pei D, Weiss S: Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271:9135-9140, 1996
41. Reich R, Martin GR: Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins 51:1-17, 1996
42. Rofstad E: Orthotopic human melanoma xenograft model systems for studies of tumor angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br J Cancer 70:804-812, 1994
43. Rozanov D, Deryugina E, Ratnikov B, Monosov E, Marchenko G, Quigley J, Strongin A: Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail (Cys (574), the active site Glu (240), and furin cleavage motifs in oligomelization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J Biol Chem 276:25705-25714, 2001
44. Rozanov D, Ghebrehiwet B, Ratnikov B, Monosov E, Deryugina E, Strongin A: The cytoplasmic tail peptide sequence of membrane type-1 matrix metalloproteinase (MT1-MMP) directly binds to gC1qR, a compartment-specific chaperon-like regulatory protein. FEBS Lett 527:51-57, 2002
45. Rudolph L, Matrisian L: Matrix metalloproteinases in remodeling of normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia 3:177-189, 1998
46. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (London) 370:61-65, 1994
47. Sato H, Okada Y, Seiki M: Membrane-type matrix metalloproteinases (MT-MMP) in cell invasion. Thromb Haemost 78:497-500, 1997
48. Seftor R, Seftor E, Koshikawa N, et al: Cooperative interactions of laminin 5 c2 chain, matrix metalloproteinase-2, and membrane type-1 matrix metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 61:6322-6327, 2001
49. Skubitz APN, Bast RC, Wayner EA, Letourneau PC, Wilke MS: Expression of alpha6 and beta4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin. Am J Pathol 148:1445-1461, 1996
50. Snow D, Smith J, Gurwell J: Binding characteristics of chondroitin sulfate proteoglycans and laminin-1, and correlative neurite outgrowth behaviors in a standard tissue culture choice assay. J Neurobiol 51:285-301, 2002
51. Sounni N, Baramova E, Munaut C, Maquoi E, Frankenne F, Foidart J, Noel A: Expression of membrane type I matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization. Int J Cancer 98:23-28, 2002a
52. Sounni N, Hajitou L, Frankenne F, et al: MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 16:555-564, 2002b
53. Yu Q, Stamenkovic I: Cell surface localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 14:163-176, 2000
54. Stetler-Stevenson W, Jiotta L, Kleiner D: Extracellular matrix 6. Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7:1434-1438, 1993
55. Takahashi K, Eto H, Tanabe KK: Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int J Cancer 80:387-395, 1999
56. Tukey J: Data-based graphics: Visual display in the decades to come. Stat Sci 5:327-339, 1990
57. Valente P, Fassina G, Melchiori A, et al: TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis [published erratum appears in Int J Cancer 80:485, 1999]. Int J Cancer 75:246-253, 1998
58. Wesley U, Albino A, Tiwari S, Houghton A: A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 190:311-322, 1999
59. Williamson D, Parker R, Kendrick J: The box-plot: A simple visual method to interpret data. Ann Intern Med 110:916-921, 1989
60. Yamamura K, Kibbey M, June S, Kleinman H: Effect of matrigel and laminin peptide YIGSR on growth and metastasis. Semin Cancer Biol 259-265, 1993
61. Yana I, Weiss S: Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 11:2387-2401, 2000
62. Zhuge Y, Xu J: Rac1 mediates type I collagen-dependent MMP-2 activation. J Biol Chem 276:16248-16256, 2001